In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

VytronUS raises $31.6mm through Series B round

Executive Summary

VytronUS Inc. raised $31.6mm through an oversubscribed Series B round. New investor Apple Tree Partners led and was joined by other first-time backers BioStar Ventures, Windham Venture Partners, and Abbott Laboratories, along with returning buyers New Enterprise Associates (NEA) and others. AppleTree and BioStar join VytronUS' board. The company will use the proceeds to continue developing its LICU (Low-Intensity Collimated Ultrasound) cardiac imaging and ablation system for atrial fibrillation.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • Ultrasound
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies